Treatment Horizons

Treatment Horizons

Dual Regimens in Trials Show Promise

The Power of Two Dual regimens show promise in clinical trials by Chael Needle At the International AIDS Conference in Amsterdam last July, ViiV Healthcare shared its...

FDA Approves New HIV Treatments

The U.S. Food and Drug Administration (FDA) has approved pharmaceutical giant Merck’s Delstrigo and Pifeltro for the treatment of HIV-1 infection in adult patients...

An HIV Injectable Regimen Comes of Age

Without the Pill Box? The First Long-Acting Injectable Regimen for Individuals Living with HIV Comes of Age by Mel Baker A funny thing happened on the way to...

TAG’s Pipeline Report

Pipeline Report Treatment Action Group provides updates on treatments for HIV, HCV & TB by Hank Trout Treatment Action Group (TAG) has announced the release of the...

ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment

ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment Findings from the GEMINI and TANGO studies, reported at the 10th International AIDS Society...

LATEST POSTS

Vaughn Frisby: Advocate

Vaughn Frisby “Those who make the worst of their time most complain about its shortness.”—La Bruyere Sadly, this describes your Ruby to a “T.” I’m always...

Age Strong Campaign

Life of David Hockney: Review

Andrew Faulk, MD: Advocate